Cue Biopharma, Inc. CUE
4.50 USD -0.26 (-5.46%)
Regular-session close
4.27 -0.23 -5.11%
After hours · Nov 19, 7:30 PM ET
3.85 Day range 5.16
2.83 52-week range 45.50
- YTD
- -50.82%
- 1 year
- -74.14%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Akanda (NASDAQ:AKAN) shares rose 66.8% to $3.42 during Wednesday's regular session. The market value of their outstanding shares is at $5.4 million. Cue Biopharma (NASDAQ:CUE) shares rose…
benzinga.com Dow Falls Over 300 Points; Nvidia Posts Upbeat Earnings U.S. stocks fell as the Dow slid 300+ points; Nvidia beat Q3 estimates, while energy, commodities and European markets declined.benzinga.com B. Riley Securities Reiterates Buy on Cue Biopharma, Lowers Price Target to $25 B. Riley Securities analyst Mayank Mamtani reiterates Cue Biopharma (NASDAQ:CUE) with a Buy and lowers the price target from $83 to $25.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) shares rose 169.8% to $20.16 during Tuesday's regular session. The market value of their outstanding shares is at $1.5 billion. As per the press release,…
benzinga.com S&P 500 Down 1%; Disney Posts Upbeat Earnings U.S. stocks fell over 1%; Disney beat estimates, while SLS and GP surged. Oil, gold and silver rose as global markets mostly declined.
benzinga.com Dow Falls Over 200 Points; US Retail Sales Rise 0.2% In October U.S. stocks were mixed as the Dow fell 200+ points; retail sales rose 0.2%, oil gained 1.5%, and SLS surged 177%.benzinga.com Cue Biopharma Q3 EPS $(4.74) Misses $(2.24) Estimate, Sales $132.000K Miss $1.033M Estimate Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(4.74) per share which missed the analyst consensus estimate of $(2.24) by 111.61 percent. This is a 113.51 percent decrease over losses of…
globenewswire.com Cue Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights BOSTON, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical stage biopharmaceutical company targeting transformative therapies for immune-mediated diseases, today reported…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Revolution Medicines (NASDAQ:RVMD) stock rose 14.1% to $227.83 during Wednesday's after-market session. The market value of their outstanding shares is at $41.6 billion. As per the news, the…
